Moderna Is About to Begin Trials for HIV Vaccine Based on COVID-19 Research
Moderna, the biotech company that developed one of the first COVID-19 vaccines last year, is hoping to break new ground this week in fighting another pandemic: HIV/AIDS. The company will soon begin human trials for their mRNA-based vaccine, according to information posted to the National Institute of Health's (NIH) clinical trials database last week.
https://www.them.us/story/moderna-begins-hiv-vaccine-trials-covid-19-research?utm_source=tldrnewsletter
Seonglae Cho
